| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
3
2
5
5
2
|
|
Zacks Investment Research
4
(Sell)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
B+
(Buy)
|
Fund Holdings
The fund is overweight in healthcare companies with nearly twice the allocation of similar funds. As of Sept. 30, 2010, about 55 percent of its holdings were considered mid-cap stocks. Much of the rest of its portfolio consisted of newer additions of small-cap stocks. The fund did not own any media or telecom companies in the third quarter of 2010.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 3.34 | 3.34 |
| Stocks | 90.85 | 90.85 |
| Bonds | 0.0 | 0.0 |
| Other | 0.09 | 0.09 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 5.71 | 5.71 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Church & Dwight Company, Inc. | CHD | 14.21 | 2.76 |
| AptarGroup, Inc. | ATR | 20.18 | 2.25 |
| Westinghouse Air Brake Technologies Corp | WAB | 26.76 | 2.05 |
| Compass Minerals International, Inc. | CMP | 17.37 | 2.04 |
| Oceaneering International | OII | 34.58 | 1.9 |
| Solera Holdings, Inc. | SLH | 2.82 | 1.84 |
| Clarcor Inc. | CLC | 15.7 | 1.83 |
| Henry Schein, Inc. | HSIC | 19.75 | 1.6 |
| Haemonetics Corporation | HAE | 0.54 | 1.6 |
| Polaris Industries, Inc. | PII | 14.81 | 1.54 |
